β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 32, Issue 1, Pages 832-840
Publisher
Informa UK Limited
Online
2017-06-20
DOI
10.1080/14756366.2017.1332056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Bicarbonate as a Trigger and Genes Involved with Extracellular DNA Export in Mycobacterial Biofilms
- (2016) Sasha J. Rose et al. mBio
- The Zebrafish Breathes New Life into the Study of Tuberculosis
- (2016) Henna Myllymäki et al. Frontiers in Immunology
- The Carbonic Anhydrase Inhibitor Ethoxzolamide Inhibits the Mycobacterium tuberculosis PhoPR Regulon and Esx-1 Secretion and Attenuates Virulence
- (2015) Benjamin K. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fit for consumption: zebrafish as a model for tuberculosis
- (2014) M. R. Cronan et al. Disease Models & Mechanisms
- Adequate Th2-Type Response Associates with Restricted Bacterial Growth in Latent Mycobacterial Infection of Zebrafish
- (2014) Milka Marjut Hammarén et al. PLoS Pathogens
- Insights into bacterial CO2 metabolism revealed by the characterization of four carbonic anhydrases in Ralstonia eutropha H16
- (2014) Claudia S Gai et al. AMB Express
- Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish
- (2013) Kevin Takaki et al. Nature Protocols
- Applying insights from biofilm biology to drug development — can a new approach be developed?
- (2013) Thomas Bjarnsholt et al. NATURE REVIEWS DRUG DISCOVERY
- Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases fromMycobacterium tuberculosis
- (2012) Alfonso Maresca et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- DNA Cloning, Characterization, and Inhibition Studies of an α-Carbonic Anhydrase from the Pathogenic Bacterium Vibrio cholerae
- (2012) Sonia Del Prete et al. JOURNAL OF MEDICINAL CHEMISTRY
- An In Vivo Platform for Rapid High-Throughput Antitubercular Drug Discovery
- (2012) Kevin Takaki et al. Cell Reports
- Mycobacterium marinum Causes a Latent Infection that Can Be Reactivated by Gamma Irradiation in Adult Zebrafish
- (2012) Mataleena Parikka et al. PLoS Pathogens
- Dithiocarbamates strongly inhibit the β-class carbonic anhydrases fromMycobacterium tuberculosis
- (2011) Alfonso Maresca et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Bacterial Carbonic Anhydrases as Drug Targets: Toward Novel Antibiotics?
- (2011) Claudiu T. Supuran Frontiers in Pharmacology
- TubercuList – 10 years after
- (2010) Jocelyne M. Lew et al. TUBERCULOSIS
- The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection
- (2009) J. Muse Davis et al. CELL
- The α and β Classes Carbonic Anhydrases from Helicobacter pylori as Novel Drug Targets
- (2008) Hiroaki Takeuchi et al. CURRENT PHARMACEUTICAL DESIGN
- Cloning, polymorphism, and inhibition of β-carbonic anhydrase of Helicobacter pylori
- (2008) Saori Morishita et al. JOURNAL OF GASTROENTEROLOGY
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now